The recalled Philips CPAP devices have been associated with significant health risks due to the degradation of the polyester-based polyurethane (PE-PUR) foam used within them.
The massive Philips CPAP recall came after the Food and Drug Administration (FDA) discovered potential risks with the sound abatement foam in the company’s CPAP machine products.
This foam is designed to reduce sound and vibration.
Unfortunately, it can break down over time, leading to the release of small foam particles or chemicals that may not be visible to the user.
These particles can make their way through the CPAP machine or BiPAP machine, eventually being inhaled by users.
The inhalation of these particles can put users at risk for various conditions, including potentially life-threatening lung injuries and even lung cancer.
Risks Associated With PE-PUR Sound Abatement Foam
PE-PUR foam in Philips Respironics devices was intended to reduce sound and vibration, enhancing the comfort and usability of their sleep and respiratory care products.
However, this foam can degrade under certain conditions, such as exposure to high humidity and temperatures or the use of unapproved cleaning methods like ozone cleaners.
When it degrades, the foam can release potentially toxic and carcinogenic chemicals and particles that users might inhale or ingest, posing serious health risks.
Alleged risks associated with foam degradation include:
- Inhalation and Ingestion Risks: Users may inhale or ingest foam particles or chemicals, potentially leading to serious health consequences.
- Toxic and Carcinogenic Effects: There are concerns about the potential toxicity and carcinogenicity of the emitted particles or chemicals from the degraded foam.
Severe Health Problems Reported by Plaintiffs
Philips Respironics devices have been linked to significant health problems due to the breakdown of PE-PUR foam, which can emit toxic and carcinogenic particles and chemicals.
Users of these devices may inhale or ingest foam particles and harmful substances, leading to potential injuries, respiratory issues, and even cancer.
Plaintiffs in the Philips CPAP Lung Injury Lawsuit have reported experiencing severe health problems, notably:
- Lung Injuries: Many individuals have suffered from lung injuries attributed to the inhalation of degraded foam particles or chemicals from Philips CPAP devices.
- Symptoms of lung injuries can include difficulty breathing, chest pain, persistent coughing, and other respiratory issues.
- Potential Links to Cancer: There are concerns and ongoing investigations into potential links between the use of these CPAP devices and an increased risk of cancer.
- Studies are exploring whether exposure to certain chemicals or particles from the degraded foam may contribute to cancer development.
These reported health problems highlight the serious nature of the issues associated with the Philips CPAP devices and underscore the importance of seeking appropriate medical evaluation and legal guidance if affected by these devices.
